Skip to main content

MCKESSON CORP

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

MCK$1,082.59+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Financial Condition, Liquidity, and Capital Resources

We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities, commercial paper program, and other borrowings will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain adequately capitalized, including access to liquidity from our $4.0 billion revolving credit facility and $1.0 billion 364-day credit facility. At September 30, 2025, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.

The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown:

Six Months Ended September 30,
(Dollars in millions)20252024Change
Net cash provided by (used in):
Operating activities$1,502$720$782
Investing activities(3,588)(373)(3,215)
Financing activities215(2,408)2,623
Effect of exchange rate changes on cash, cash equivalents, and restricted cash24123
Change in cash, cash equivalents, and restricted cash classified as Assets held for sale—(14)14
Net change in cash, cash equivalents, and restricted cash$(1,847)$(2,074)$227

Operating Activities

Operating activities provided cash of $1.5 billion and $720 million during the six months ended September 30, 2025 and 2024, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms.

For the six months ended September 30, 2025, net cash used by operating activities increased by $782 million compared to the same prior year period. This increase was primarily due to the following:

the Company’s net income increased by $747 million and was impacted by lower net non-cash items of $450 million, compared to the same prior year period driven by factors discussed in more detail in the“Overview of Consolidated Results” section of this Financial Review;

an increase in net cash of $1.2 billion related to accounts receivable is primarily due to favorable timing of collections;

an increase in cash from other assets and liabilities primarily related to lower contract liability payments; and

a decrease in cash of $1.1 billion related to accounts payable as a result of customary vendor payment scheduling, partially offset by an increase in cash of $111 million due to lower inventory requirements during the period.

Table of ContentsMD&A Index

Investing Activities

Investing activities used cash of $3.6 billion and $373 million during the six months ended September 30, 2025 and 2024, respectively. Investing activities for the six months ended September 30, 2025 includes $3.4 billion of net cash payments for acquisitions, including $2.5 billion and $871 million for the acquisitions of the interests in Core Ventures and PRISM Vision, respectively, as discussed in further detail in Financial Note 2, “Business Acquisitions and Divestitures,” to the accompanying condensed consolidated financial statements in this Quarterly Report. Investing activities for the six months ended September 30, 2025 and 2024 includes $385 million and $385 million, respectively, in capital expenditures for property, plant, and equipment and capitalized software. Investing activities for the six months ended September 30, 2025 was also impacted by the receipt of proceeds of $133 million related to the sale of businesses and investments, as discussed in Financial Note 10, “Fair Value Measurements,” to the accompanying condensed consolidated financial statements included in this Quarterly Report.

Investing activities for the six months ended September 30, 2024 was also impacted by the receipt of proceeds of $92 million related to the sale of equity securities, as discussed in Financial Note 10, “Fair Value Measurements,” to the accompanying condensed consolidated financial statements included in this Quarterly Report.

Financing Activities

Financing activities provided cash of $215 million and used cash of $2.4 billion during the six months ended September 30, 2025 and 2024, respectively, which includes $1.4 billion and $2.0 billion of cash paid for share repurchases, respectively, as well as $179 million and $162 million of cash paid for dividends, respectively. Financing activities for the six months ended September 30, 2024 also includes cash receipts and cash payments each of $2.3 billion and $6.9 billion for the six months ended September 30, 2025 and 2024, respectively, related to short-term borrowings of commercial paper.

On May 30, 2025, we completed a public debt offering of 4.65% Notes due May 30, 2030 in a principal amount of $650 million, 4.95% Notes due May 30, 2032 in a principal amount of $650 million, and 5.25% Notes due May 30, 2035 in a principal amount of $700 million, for total proceeds received, net of discounts and debt offering expenses, of $2.0 billion. The net proceeds from these notes were utilized to fund the purchase of the interest in Core Ventures. Refer to Financial Note 8, “Debt and Financing Activities,” to the accompanying condensed consolidated financial statements in this Quarterly Report for additional information.

On September 10, 2024, we completed a public offering of 4.25% Notes due September 15, 2029 in a principal amount of $500 million. Proceeds received from this note issuance, net of discounts and offering expenses, were approximately $496 million. We utilized the net proceeds from this note issuance along with cash on hand to redeem our $500 million outstanding principal amount of 5.25% Notes due February 15, 2026 prior to maturity at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest through the settlement date.

Cash used for other financing activities generally includes the cash value of shares surrendered for tax withholding and payments to noncontrolling interests.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.